Invented by Rajendra A. Gopalakrishna, Acalvio Technologies Inc
A testing environment cyber vaccine is a software solution that is designed to simulate cyber attacks and test the security measures of an organization’s IT infrastructure. It helps businesses identify vulnerabilities and weaknesses in their systems and provides them with the necessary tools to strengthen their security posture.
The market for testing environment cyber vaccine is driven by the increasing number of cyber attacks and data breaches. According to a report by IBM, the average cost of a data breach in 2020 was $3.86 million. This has led to businesses investing heavily in cybersecurity solutions to protect their systems and data from cyber threats.
The market for testing environment cyber vaccine is also driven by the increasing adoption of cloud-based solutions and the Internet of Things (IoT). With more businesses moving their operations to the cloud and connecting their devices to the internet, the risk of cyber attacks has increased significantly. A testing environment cyber vaccine can help businesses identify vulnerabilities in their cloud-based solutions and IoT devices and provide them with the necessary tools to secure their systems.
The market for testing environment cyber vaccine is segmented based on deployment mode, organization size, and vertical. Based on deployment mode, the market is segmented into on-premise and cloud-based solutions. On-premise solutions are installed on the organization’s premises, while cloud-based solutions are hosted on the cloud and accessed through the internet.
Based on organization size, the market is segmented into small and medium-sized enterprises (SMEs) and large enterprises. SMEs are expected to have a higher growth rate in the market as they are more vulnerable to cyber attacks and have limited resources to invest in cybersecurity solutions.
Based on vertical, the market is segmented into banking, financial services, and insurance (BFSI), healthcare, government, IT and telecom, and others. The BFSI sector is expected to have the largest market share as it deals with sensitive financial information and is a prime target for cyber attacks.
In conclusion, the market for testing environment cyber vaccine is expected to grow significantly in the coming years as businesses and organizations become more aware of the importance of cybersecurity. With the increasing number of cyber threats and attacks, it has become crucial for businesses to invest in robust cybersecurity solutions to protect their systems and data. A testing environment cyber vaccine can help businesses identify vulnerabilities in their systems and provide them with the necessary tools to strengthen their security posture.
The Acalvio Technologies Inc invention works as follows
Systems, methods, computer program products, and other related items are provided for a technique of cyber-vaccination. The technique can be implemented in different ways. It includes determining the characteristics of a test environment. The testing environment is used to analyse malware programs. This technique may also include configuring the characteristics of a production device to resemble the testing environment. The production network device will be used to operate the network, not for malware analysis.
Background for Testing environment cyber vaccine
Cyber vaccination and cyber antibodies borrow concepts from medicine. In medicine, vaccines are often used to induce the body to produce antibodies against an organism. In the world of computing, malware can also be used to protect computers from infection by the same malware.
Systems, methods, computer-implemented method, and computer program products are provided for a technique of cyber-vaccination. The cyber-vaccination method can be implemented in various ways, including using a network system that has been infected with a malware program and determining the marker created by the malware. The marker can indicate to the malware that the network device is infected. The marker can be determined by determining the location of the marker. The technique also includes identifying other network devices which have not been previously infected with the malware program. The technique also includes automatically distributing the copies of marker. The identified network device can then place the marker according to the predetermined placement on the network device.
In various implementations, the method of determining the marker using the cyber-vaccination technique involves comparing a snapshot of an infected device to a snapshot of a device that is not infected. The first snapshot was captured before the malware infection, while the second was taken after. The marker can be determined by identifying one or more differences in the first and second snapshots, and selecting a difference among them as the marker.
In some implementations, determining marker also includes determining changes in the system registry of the device. In some implementations determining the mark includes determining a modification to the file system of the device. In some implementations determining the mark includes identifying the process running on a network device. In some implementations identifying the marker also includes identifying the user who is logged into the network device. In some implementations determining the mark includes determining changes in the system memory of the device. In some implementations identifying the open port of a network device is part of determining the mark.
In various implementations, a cyber-vaccination method includes further identifying the network devices as being infected with the malware program. The technique may also include activating the malware on the network device in various implementations.
In various implementations, the presence of a marker from one or more network devices on a network device that is not infected represents the network device to be infected with the malware program.
In various implementations the marker is determined in real-time.
In some implementations, the automatic distribution of copies of the mark includes the use a remote management tool.
Also, provided are computer-program products, systems, methods and computer-programs for a Cyber-Antibody Technique. The cyber-antibody method includes, in various implementations: using a device on a network that is infected by an unknown malware program. This device will be used to monitor the packets it sends onto a computer network. The technique also includes identifying the packet associated with an unknown malware program. The packet can then be selected from the monitored packets. Identifying the packet may include determining its characteristic. The technique also includes identifying packets with a similar characteristic to that of the identified packet. In addition, the technique includes inserting data related to a malware program known in one or more of the other packets. The technique also includes automatically disseminating the characteristic of the package. The characteristic can also be used at another network device to identify other packets that have a similar characteristic to the packet.
In various implementations of the cyber antibody technique identifying a packet associated with a malware program also includes determining the process that created the packet.
In various implementations, determining a packet’s characteristic includes looking at the header portion. In some implementations examining the header part includes identifying a source or destination address. “a network service type or label, an identifier for the service, a class or a label.
In various implementations, determining a packet’s characteristic includes looking at the payload of the package. In some implementations identifying a character string is part of examining the payload.
In various implementations, data associated with a known malware program can infect one or more packets that contain the known malicious program. In some implementations the network security infrastructure device blocks the known malware program.
In various implementations, the monitoring of packets can be done for minutes, hours or days.
In various implementations, cyber-antibody technology also includes receiving a characteristic new from the network. The new characteristic could be linked to a new malware program. The technique also includes configuring the process with the characteristic. The process can insert a digital signature into other packets that have a similar feature.
In various implementations the identification of the packet takes place in real-time.
In various implementations, automatic distribution of the characteristic also includes remote administration tools.
Also, provided are computer-program products, systems, methods and computer-programs for a generic Cyber-vaccination Technique. The generic cyber-vaccination method includes using a device on a network to determine the characteristics of a test environment. The testing environment may be used to analyze malware. The technique also includes configuring production network devices used for network operations that exclude malware analysis. The production network device may be configured using characteristics from the testing environment. The production network device can be configured with characteristics to make it resemble the test environment.
In various implementations, a virtual machine is included in the testing environment for the generic cyber-vaccination method. In some implementations, one or more of the characteristics of the test environment are a process that is associated with a simulated machine. In some implementations, a specific Media Access Control address (MAC) is included in the characteristics. In some implementations, the characteristics are an entry in the system registry. The characteristics can be a part of the structure or content in a filesystem. In some implementations, characteristics may include the execution path of the process associated with the test environment.
In various implementations, the generic technique of cyber-vaccination includes automatically disseminating the characteristics the testing environment to other network devices.
In various implementations, cyber-vaccination techniques include configuring network devices with one or more characteristics.
Click here to view the patent on Google Patents.
Leave a Reply